METAB-HTX is a prospective, longitudinal cohort study evaluating cardiac and systemic metabolism in heart transplant recipients.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
diastolic and systolic left ventricular function
Timeframe: Baseline, 1 year, and 2 years after heart transplantation
CAV diagnosis
Timeframe: Baseline, 1 year, and up to 24 months
Allograft rejection will be evaluated by endomyocardial biopsy
Timeframe: 1 year and 5 years after heart transplantation
Worsening of kidney function
Timeframe: Baseline, 1 year, and 2 years after heart transplantation
Infection requiring heath care professional interventions
Timeframe: Baseline, 1 year, and 2 years after heart transplantation
Diagnosis of malignencies
Timeframe: Baseline, 1 year, and 2 years after heart transplantation
Worsening of metabolic derangements
Timeframe: Baseline, 1 year, and 2 years after heart transplantation
Liver deterioration
Timeframe: Baseline, 1 year, and 2 years after heart transplantation